Chunhua Ma, Junbiao Chang, Bin Yu. Sunlenca® (Lenacapavir): A first-in-class, long-acting HIV-1 capsid inhibitor for treating highly multidrug-resistant HIV-1 infectionJ. Acta Pharmaceutica Sinica B, 2024, 14(12): 5512-5514. DOI: 10.1016/j.apsb.2024.08.009
Citation: Chunhua Ma, Junbiao Chang, Bin Yu. Sunlenca® (Lenacapavir): A first-in-class, long-acting HIV-1 capsid inhibitor for treating highly multidrug-resistant HIV-1 infectionJ. Acta Pharmaceutica Sinica B, 2024, 14(12): 5512-5514. DOI: 10.1016/j.apsb.2024.08.009
shu

Sunlenca® (Lenacapavir): A first-in-class, long-acting HIV-1 capsid inhibitor for treating highly multidrug-resistant HIV-1 infection

    Abstract
    • FullText(HTML)
  • loading
    • References (10)
    • Relative Articles
  • Supplements (0)

Catalog

    Copyright © 2014 Editorial Office of Acta Pharmaceutica Sinica

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return